Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CAPHA PHARMACEUTICALS Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
GREEN THUMB INDUSTRIES | 4,958 | -2,11 % | Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold? | ||
SINOPHARM | 2,112 | +1,39 % | Minimaler Kursabschlag bei der Sinopharm Group-Aktie (2,033 €) | Die Wertschätzung für den Anteilsschein der Sinopharm Group hat sich am Aktienmarkt heute kaum geändert. Zuletzt zahlten Investoren für das Papier 2,03 Euro. Jahreschart der Sinopharm Group Ltd-Aktie... ► Artikel lesen | |
INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
CSPC PHARMA | 0,943 | +1,29 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURNS | ||
ALNYLAM PHARMACEUTICALS | 277,90 | -0,36 % | Truist Securities initiates Alnylam Pharmaceuticals stock with Buy rating | ||
NEKTAR THERAPEUTICS | 20,800 | -0,95 % | Nektar Therapeutics Prices $100 Mln Public Offering Of Common Stock At $23.50 Per Share | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR), a clinical-stage biotech firm specializing in immunotherapy, has priced its underwritten public offering of approximately $100 million in common... ► Artikel lesen | |
CASSAVA SCIENCES | 2,186 | +1,82 % | Cassava Sciences, Inc.: Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development | AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a clinical-stage biotechnology company focused on developing novel, investigational... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,879 | -1,13 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
ADASTRA | 0,157 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,586 | +2,06 % | SELLAS Life Sciences Group, Inc.: SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study | The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30... ► Artikel lesen | |
ACADIA PHARMACEUTICALS | 19,520 | -0,41 % | What Analysts Are Saying About ACADIA Pharmaceuticals Stock | ||
CATALYST PHARMACEUTICALS | 17,915 | -0,31 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 |